Quisinostat
From Infogalactic: the planetary knowledge core
File:Quisinostat.svg | |
Systematic (IUPAC) name | |
---|---|
N-Hydroxy-2-[4-({[(1-methyl-1H-indol-3-yl)methyl]amino}methyl)-1-piperidinyl]-5-pyrimidinecarboxamide
|
|
Identifiers | |
ATC code | None |
PubChem | CID: 11538455 |
ChemSpider | 9713236 |
Synonyms | JNJ-26481585 |
Chemical data | |
Formula | C21H26N6O2 |
Molecular mass | 394.470 g/mol |
|
|
|
Quisinostat (USAN;[1] development code JNJ-26481585) is an experimental drug candidate for the treatment of cancer. It is a "second generation" histone deacetylase inhibitor with antineoplastic activity.[2][3][4]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Experimental cancer drugs
- Antineoplastic drugs
- Pyrimidines
- Indoles
- Hydroxamic acids
- Piperidines
- Johnson & Johnson
- Antineoplastic and immunomodulating drug stubs